Gandeeva and Zymeworks partner on cryo-EM antibody structure work
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St set for lower open as Big Tech earnings rekindle AI spending worries, oil jumps
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Dollar hits fresh 40-year high versus yen, edges higher against euro
Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery
June 18, 2026 8:00 AM EDTVancouver-based biotech companies Gandeeva Therapeutics and Zymeworks have partnered to generate cryo-EMbased structural data to augment antibody drug discovery.
VANCOUVER, BC, June 18, 2026 /PRNewswire/ - Gandeeva Therapeutics, Inc., a biotech at the forefront of cryo-electron microscopy (cryo-EM)driven drug design, and... More
